Peking University Shenzhen Hospital
Clinical trials sponsored by Peking University Shenzhen Hospital, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New model aims to predict dangerous blood pressure drop in C-Section patients Results expected Sep 2026 (estimated)
-
Immune cell therapy takes on advanced cancers in early trial
Disease control Not yet recruitingThis early-phase study tests a new treatment called CAR-DC for people with advanced solid tumors (like lung, liver, or stomach cancer) that have not responded to standard care. The therapy uses a patient's own immune cells, modified in a lab to recognize and attack cancer cells. …
Early phase 1 • Sponsor: Peking University Shenzhen Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New model aims to predict dangerous blood pressure drop in C-Section patients
Knowledge-focused Not yet recruitingThis study aims to create a risk prediction model for low blood pressure (hypotension) after spinal anesthesia in women undergoing planned cesarean delivery. Researchers monitor heart rate, blood pressure, perfusion index, and ECG/SpO₂ waveforms before and during surgery to ident…
Sponsor: Peking University Shenzhen Hospital • Aim: Knowledge-focused
Last updated Jul 29, 2026 00:00 UTC